Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 14 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 10220002

    Controlled-release peptide compositions and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  2. EP 3442949

    KONTRASTMITTEL

    BRACCO IMAGING SPA [IT] · Granted Feb 20, 2019 · Expires Feb 15, 2039

    granted

  3. US 10207013

    Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  4. US 10208035

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  5. US 10206897

    Creatine ester anti-inflammatory compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  6. US 10202584

    Red-shifted luciferase-luciferin pairs for enhanced bioluminescence

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  7. US 10201516

    Targeting K-Ras-mediated signaling pathways and malignancy by prostratin

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  8. US 10189807

    Tetrahydrothiophene-based GABA aminotransferase inactivators

    Northwestern University · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  9. US 10179155

    Phosphodiesterase-4 inhibiting phytochemical compositions

    Nature's Sunshine Products, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  10. US 10179151

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  11. US 10172831

    Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them

    The Regents of the University of California · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  12. US 2018362511

    DIMERIC CONTRAST AGENTS

    BRACCO IMAGING SPA [IT] · Granted Dec 20, 2018 · Expires Dec 15, 2038

    granted

  13. US 10144767

    Anti-microbial peptides and coatings

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  14. US 10137121

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  15. US 10132810

    Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

    Nektar Therapeutics · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  16. US 10130600

    Lipid scavenging in Ras cancers

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  17. US 10125134

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  18. US 10113170

    Preventing and treating inflammatory skin diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  19. US 10081668

    Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  20. US 10064836

    Antiparasitic compositions and methods

    TYRATECH, INC. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  21. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  22. US 10052369

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  23. US 10053706

    Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  24. US 10039725

    Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.